She brings her global experience across multiple therapeutic areas to her current role leading operations at YPrime. In this ...

Alison has more than 35 years of broad experience delivering clinical trials to sponsors with a patient centric mindset.

The German big pharma will submit a new drug application to the US FDA after success at phase 3 for nerandomilast.

One year after a rejection by the US Food and Drug Administration (FDA), the UK firm F2G has raised $100 million to push its ...

Motif, a fast-growing company in the clinical research technology sector, has taken a significant step in expanding its ...

With innovative and flexible lab and manufacturing solutions being a critical success factor in drug development and delivery, SmartLabs, was delighted to announce the raise of $48 million series C ...

This complexity is being driven by various factors, including efforts to make treatments more effective and to avoid side-effects, targeting new modes of action, and improving target specificity. The ...

Rachel Sha has had a colorful career not without its challenges, but she urges women in the science industry to have ...

In the crowded landscape of health tech, ethical marketing has emerged as a crucial differentiator for companies striving to stand out. Leslie Pascaud, chief marketing officer at ObvioHealth, believes ...

Recent investments by major pharmaceutical companies signal a growing confidence in artificial intelligence’s (AI's) ...